Cargando…

Leprosy detection rate in patients under immunosuppression for the treatment of dermatological, rheumatological, and gastroenterological diseases: a systematic review of the literature and meta-analysis

BACKGROUND: Recently developed immunosuppressive drugs, especially TNF antagonists, may enhance the risk of granulomatous infections, including leprosy. We aimed to evaluate the leprosy detection rate in patients under immunosuppression due to rheumatological, dermatological and gastroenterological...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barroso, Daniel Holanda, Brandão, Jurema Guerrieri, Andrade, Elaine Silva Nascimento, Correia, Ana Clara Banhatto, Aquino, Danielle Costa, Chen, Ana Carolina Rios, Vernal, Sebastian, de Araújo, Wildo Navegantes, da Mota, Lícia Maria Henrique, Sampaio, Raimunda Nonata Ribeiro, Kurizky, Patrícia Shu, Gomes, Ciro Martins
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045377/ https://www.ncbi.nlm.nih.gov/pubmed/33849463 http://dx.doi.org/10.1186/s12879-021-06041-7

Ejemplares similares

A comprehensive systematic review of leishmaniasis in patients undergoing drug-induced immunosuppression for the treatment of dermatological, rheumatological and gastroenterological diseases
por: Kurizky, Patrícia Shu, et al.
Publicado: (2020)

Effectiveness and safety of multidrug therapy containing clofazimine for paucibacillary leprosy and clarithromycin for rifampicin-resistant leprosy: a systematic review and meta-analysis
por: Montezuma, Thais, et al.
Publicado: (2023)

Comparison of cardiotoxicity between N-methyl-glucamine and miltefosine in the treatment of American cutaneous leishmaniasis()()
por: Barroso, Daniel Holanda, et al.
Publicado: (2021)

No evidence for cardiotoxicity of miltefosine – Reply()
por: Barroso, Daniel Holanda, et al.
Publicado: (2022)

The accuracy of the Montenegro skin test for leishmaniasis in PCR-negative patients
por: Pinheiro, Ana Bárbara Sapienza, et al.
Publicado: (2020)

The interference of polypharmacy and the importance of clinical pharmacy advice in the treatment of leprosy: a case-control study
por: Cerqueira, Selma Regina Penha Silva, et al.
Publicado: (2020)

Switching Between Reference Biologics and Biosimilars for the Treatment of Rheumatology, Gastroenterology, and Dermatology Inflammatory Conditions: Considerations for the Clinician
por: Moots, Robert, et al.
Publicado: (2017)

Meglumine antimoniate was associated with a higher cure rate than liposomal amphotericin B in the treatment of American tegumentary leishmaniasis: A retrospective cohort study from a Leishmania braziliensis-endemic area
por: Barroso, Daniel Holanda, et al.
Publicado: (2022)

The Presence of Leishmania braziliensis DNA in the Nasal Mucosa of Cutaneous Leishmaniasis Patients and the Search for Possible Clinical and Immunological Patterns of Disease Progression: A Cross Sectional Study
por: Barroso, Daniel Holanda, et al.
Publicado: (2021)

A retrospective cohort study of the effectiveness and adverse events of intralesional pentavalent antimonials in the treatment of cutaneous leishmaniasis
por: Rodrigues, Bruna Côrtes, et al.
Publicado: (2020)

The influence of leprosy-related clinical and epidemiological variables in the occurrence and severity of COVID-19: A prospective real-world cohort study
por: Cerqueira, Selma Regina Penha Silva, et al.
Publicado: (2021)

Complementary exams in the diagnosis of american tegumentary leishmaniasis
por: Gomes, Ciro Martins, et al.
Publicado: (2014)

A Pilot Randomized Clinical Trial: Oral Miltefosine and Pentavalent Antimonials Associated With Pentoxifylline for the Treatment of American Tegumentary Leishmaniasis
por: Martins, Sofia Sales, et al.
Publicado: (2021)

Brazilian Society of Dermatology against leprosy
por: Lastória, Joel Carlos, et al.
Publicado: (2016)

Field validation of a Leishmania (Leishmania) mexicana exo-antigens ELISA for diagnosing tegumentary leishmaniasis in regions of Leishmania (Viannia) predominance
por: Soares, Killarney Ataide, et al.
Publicado: (2015)

Toll-Like Receptors in Dermatology, Venereology, and Leprosy
por: Gandhi, Sneha, et al.
Publicado: (2021)

PD-L1 May Mediate T-Cell Exhaustion in a Case of Early Diffuse Leishmaniasis Caused by Leishmania (L.) amazonensis
por: Barroso, Daniel Holanda, et al.
Publicado: (2018)

Leprosy in a rheumatology setting: a challenging mimic to expose
por: Salvi, Sheetal, et al.
Publicado: (2013)

Recurrent cutaneous leishmaniasis*
por: Gomes, Ciro Martins, et al.
Publicado: (2013)

Enhanced IL-6 and IL-12B Gene Expression After SARS-CoV-2 Infection in Leprosy Patients May Increase the Risk of Neural Damage
por: Santos Morais Junior, Gilberto, et al.
Publicado: (2021)

IADVL Multiple Choice Questions in Dermatology, Venereology and Leprosy
por: Dogra, Sunil
Publicado: (2023)

Lutzomyia whitmani is the main vector of American Cutaneous Leishmaniasis in the Brazilian Federal District and the most prevalent species in residential areas of the Administrative Region of Sobradinho()
por: Barreto, Mariana Boff, et al.
Publicado: (2014)

The challenge of concomitant infections in the coronavirus disease 2019 pandemic era: Severe acute respiratory syndrome coronavirus 2 infection in a patient with chronic Chagas disease and dimorphic leprosy
por: Kurizky, Patricia Shu, et al.
Publicado: (2020)

Mortality Due to Chagas Disease in Brazil According to a Specific Cause
por: da Nóbrega, Aglaêr Alves, et al.
Publicado: (2014)

Foreword: Seminars in Research 2014 Joint Experiences in Rheumatology and Dermatology
por: Costanzo, Antonio, et al.
Publicado: (2016)

Importance of collaboration of dermatology and rheumatology to advance the field for lupus and dermatomyositis
por: Werth, Victoria P., et al.
Publicado: (2021)

Oral health in patients with severe inflammatory dermatologic and rheumatologic disease
por: Kiernan, Yvonne, et al.
Publicado: (2022)

Effectiveness of interdisciplinary combined dermatology–gastroenterology–rheumatology clinical care compared to usual care in patients with immune-mediated inflammatory diseases: a parallel group, non-blinded, pragmatic randomised trial
por: Hjuler, Kasper Fjellhaugen, et al.
Publicado: (2021)

National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs)
por: Rath, Eva, et al.
Publicado: (2022)

Leprosy Mimicking Common Rheumatologic Entities: A Trial for the Clinician in the Era of Biologics
por: Rath, Deepak, et al.
Publicado: (2014)

The paradox of tegumentary leishmaniasis diagnosis: How the need for accurate and modern techniques is being addressed in low income areas
por: Kurizky, Patrícia Shu, et al.
Publicado: (2018)

Exploring Dermatomyositis through an Interdisciplinary Lens: Pearls from Dermatology and Rheumatology
por: Kassamali, Bina, et al.
Publicado: (2021)

Successful treatment of diffuse cutaneous leishmaniasis caused by Leishmania amazonensis()()
por: Sampaio, Raimunda Nonata Ribeiro, et al.
Publicado: (2021)

Accuracy of mucocutaneous leishmaniasis diagnosis using polymerase chain reaction: systematic literature review and meta-analysis
por: Gomes, Ciro Martins, et al.
Publicado: (2015)

Towards a combined pediatric rheumatology-dermatology clinic: One-year experience
por: Demirkan, Fatma Gul, et al.
Publicado: (2020)

Big Data in Gastroenterology Research
por: Alizadeh, Madeline, et al.
Publicado: (2023)

New insights at the interface between leprosy and immune-mediated rheumatic diseases
por: Cruz, Vitor Alves, et al.
Publicado: (2023)

Leprosy on the scalp
por: Macedo, Raila de Brito, et al.
Publicado: (2016)

Immunosuppressives and biologics during pregnancy and lactation: A consensus report issued by the Austrian Societies of Gastroenterology and Hepatology and Rheumatology and Rehabilitation
por: Puchner, Antonia, et al.
Publicado: (2019)

Nonmedical Switching From Originators to Biosimilars: Does the Nocebo Effect Explain Treatment Failures and Adverse Events in Rheumatology and Gastroenterology?
por: Fleischmann, Roy, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mv1umt48slacorvh2k0cq41798